The fourth dose of the Covid vaccine can be given to people over 80, RSA guests and people at risk between 60 and 79 years old.
This was clarified in a note from the Ministry of Health, Aifa, Iss and CSS, after the statement by Ema and Ecdc on the second reminder of the anti-Covid vaccine. 19 (second reminder), and the meeting of the Cts of Aifa, which indicates the methods of administration.
The indication of the fourth dose of the anti-Covid vaccine, which in Italy will be given to over 80, RSA guests and fragile between 60 and 79 years old, “At this time, this does not apply to subjects who have acquired Sars-CoV-2 infection.
after the first booster dose”.
He also reiterates “The priority to put in maximum protection all the subjects who have not yet received the first booster, and for whom this one has already been recommended – continues the note – and to promote, recalling its absolute importance, the administration of the fourth vaccine dose in all subjects with a marked alteration in the immune response due to causes related to the underlying pathology or pharmacological treatments, and to subjects undergoing a solid organ transplant. It should be recalled that for this last category, the administration of the fourth dose should be considered equivalent to a booster dose, consisting of the primary vaccination cycle of three doses”.
The note from the Ministry of Health
Given the current epidemiological situation, having regard to the joint note from the European Medicines Agency (EMA) and the European Center for Disease Prevention and Control (ECDC) of 6/04/2022 and having taken note of the opinion similar to the AIFA CTS expressed on 04/05/2022, with a view to further strengthening the protection conferred by the vaccines and in compliance with the principle of maximum precaution, it is recommended to administer a second booster to the mRNA vaccine, at the dosages authorized for booster (30 mcg in 0.3 mL for Comirnaty; 50 mcg in 0.25 mL for Spikevax), provided that s has elapsed Minimum interval of at least 120 days from the first booster dose, people: 2 80 years old, clients of residential facilities for the elderly, frail people motivated by concomitant / pre-existing pathologies (according to the attached table ¡age 260 years old. At present, this indication is not does not apply to subjects who have cont racted SARSCoV-2 infection after administration of the first booster dose. Furthermore, the priority is to provide maximum protection for all subjects who have not yet received the first booster dose, it has already been recommended to promote, recalling its absolute importance, the administration of the fourth dose in all subjects with marked impairment of the immune response, for causes related to the underlying disease or to pharmacological treatments and subjects undergoing solid organ transplantation. However, it should be remembered that, for this last category of subjects, the administration of the fourth dose must be considered equivalent to a booster dose, consisting of the primary vaccination cycle of three doses (see circular 13209- 02/20/2022 – DGPRE).